AllenChiangMD

Ophthalmology • Plymouth Meeting, PA

Retinal Disease

Retina Service of Wills Eye Hospital

Join to view full profile

Dr. Chiang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chiang's full profile

Already have an account?

Office
4060 Butler Pike
Ste 200
Plymouth Meeting, PA 19462
Phone+1 800-331-6634

Fax+1 267-420-1363

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2009 - 2011
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2006 - 2009
Scripps Mercy HospitalInternship, Transitional Year, 2005 - 2006
New York University School of MedicineClass of 2005

Certifications & Licensure

DE State Medical License 2013 - 2025
NJ State Medical License 2013 - 2025
CA State Medical License 2006 - 2024
PA State Medical License 2009 - 2024
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Top Doctor Castle-Connolly, 2023-2024
Top Doctor Philadelphia Magazine, 2023-2024
Secretariat Award AAO, 2023
Achievement Award AAO, 2020
Honor Award ASRS, 2018
Top 40 Physicians Under 40 PA Medical Society, 2017
Top Doctors Oakland Magazine, 2012
Jules Stein Eye Institute Resident Research Award UCLA
Jules Stein Eye Institute Award for Excellence in Surgery UCLA
William Tasman MD Outstanding Fellow Award Wills Eye Hospital
Join now to see all

Clinical Trials

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) Start of enrollment: 2016 Mar 29
Completed
Phase 3
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration Start of enrollment: 2018 Aug 31
Completed
Phase 3

Publications & Presentations

PubMed

5 citations
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
Asad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit
The British Journal of Ophthalmology. 2024-08-22
13 citations
Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration.
Saagar A Pandit, Bita Momenaei, Taku Wakabayashi, Hana A Mansour, Sudheshna Vemula
Ophthalmology. Retina. 2024-04-01
1 citations
VITRECTOMY FOR VITREOUS HEMORRHAGE ASSOCIATED WITH RETINAL VEIN OCCLUSION: Visual Outcomes, Prognostic Factors, and Sequelae.
Taku Wakabayashi, Neil Patel, Matthew Bough, Ankur Nahar, Young Sheng
Retina. 2023-09-01

Press Mentions

Apellis Presents Phase 3 Functional Analyses of SYFOVRE™ (Pegcetacoplan Injection) for Geographic AtrophyApril 23rd, 2023

Grant Support

Innovation GrantWills Eye HospitalPresent

Committees

Member, Wills Eye Hospital Peer Review

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American Academy of Ophthalmology - AAO
Member
American Society of Retina Specialists - ASRS
Member
The Retina Society
Member

External Links

Mid Atlantic Retinahttp://www.midatlanticretina.com
Wills Eye Hospitalhttp://www.willseye.org